* Vivani Medical Inc VANI.OQ VANI.O is expected
to report
resultson May 13 (estimated) for the period ending January
1 0001
*
* LSEG's mean analyst estimate for Vivani Medical Inc is
for a
loss of 12 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts had fallen by
about 7.7%
in the last three months.
* Wall Street's median 12-month price target for Vivani
Medical
Inc is $8.00, above its last closing price of $1.72.
This summary was machine generated May 10 at 13:40 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)